Inhibition of the CXCL12/CXCR4 axis, disrupting interaction of MM cells with BMSCs, has been reported to alleviate the protective effect of BMSCs, enhancing the sensitivity of MM cells to various drugs [1, 8]. Here, CXCL12 is linked to Miyoshi myopathy.